<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="medicina-56-00386-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">medicina-56-00386-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Treatment, action mechanism and adverse effect of the various drugs addressed in this review.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"> </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Adverse Effect</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Chloroquine and Hydroxychloroquine</td>
    <td rowspan="2" align="center" valign="middle" colspan="1">↓</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IL-1β mRNA expression in THP-1 cells.</td>
    <td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cardiovascular effects, particularly prolongation of the QT interval in the electrocardiogram and hypotension have been found with the use of several quinolines and other structurally related antimalarial drugs.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 and IL-1 in monocytes and macrophages and decreases the activity of the enzyme quinone reductase 2 [
     <xref rid="B50-medicina-56-00386" ref-type="bibr">50</xref>].
    </td>
   </tr>
   <tr>
    <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The replication of some DNA and RNA viruses [
     <xref rid="B52-medicina-56-00386" ref-type="bibr">52</xref>,
     <xref rid="B53-medicina-56-00386" ref-type="bibr">53</xref>].
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the entrance of viruses into host cells and inhibits glycosylation of viral proteins [
     <xref rid="B48-medicina-56-00386" ref-type="bibr">48</xref>].
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkalinizing the endosomal pH in the phagolysosome and by blocking the glycosylation of cellular receptor of SARS-CoV.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses phosphorylation of caspase-1 and of the p38 mitogen-activated protein kinase in THP-1 cells.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses IL-6, IL-12, TNF-α and IFN-α, β and γ [
     <xref rid="B50-medicina-56-00386" ref-type="bibr">50</xref>,
     <xref rid="B51-medicina-56-00386" ref-type="bibr">51</xref>].
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the binding of the SARS-CoV-2 to target cells [
     <xref rid="B51-medicina-56-00386" ref-type="bibr">51</xref>].
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Remdesivir</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses coronaviral replication including that of MERS-CoV and SARS-CoV [
     <xref rid="B64-medicina-56-00386" ref-type="bibr">64</xref>].
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Increase in plasma glucose levels.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Remdesivir acts on viral RNA polymerase evading proofreading by viral exo-nuclease, diminishing viral RNA production [
     <xref rid="B64-medicina-56-00386" ref-type="bibr">64</xref>,
     <xref rid="B65-medicina-56-00386" ref-type="bibr">65</xref>].
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-Inflammatory Drugs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combinations of baricitinib with direct-acting antivirals could diminish viral replication, viral infectivity and the anormal host inflammatory response [
     <xref rid="B66-medicina-56-00386" ref-type="bibr">66</xref>].
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">These drugs are metabolized in the liver and most of the metabolites produced are eliminated in urine. Therefore, their metabolism may be impaired by damage to the liver and kidneys.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Ruxolitinib, Fedratinib and Baricitinib)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the JAK-STAT signaling [
     <xref rid="B66-medicina-56-00386" ref-type="bibr">66</xref>].
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Corticosteroids</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↑</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreases the immune responses while increasing the clearance of the pathogen [
     <xref rid="B67-medicina-56-00386" ref-type="bibr">67</xref>,
     <xref rid="B68-medicina-56-00386" ref-type="bibr">68</xref>,
     <xref rid="B69-medicina-56-00386" ref-type="bibr">69</xref>].
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systemic inflammation is associated to adverse outcomes in severe cases.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The lung inflammation [
     <xref rid="B67-medicina-56-00386" ref-type="bibr">67</xref>,
     <xref rid="B68-medicina-56-00386" ref-type="bibr">68</xref>,
     <xref rid="B69-medicina-56-00386" ref-type="bibr">69</xref>].
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The treatment using corticosteroid should not be employed for lung injury induced by SARS-CoV-2.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arbidol/Umifenovir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arbidol unites to lipid and protein residues suppressing the entrance of the virus entry and its fusion, budding, replication, assembly and viral resistance [
     <xref rid="B70-medicina-56-00386" ref-type="bibr">70</xref>,
     <xref rid="B71-medicina-56-00386" ref-type="bibr">71</xref>,
     <xref rid="B72-medicina-56-00386" ref-type="bibr">72</xref>].
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arbidol has only been used with a pharmacological approach and therefore, there are insufficient data on its toxicity.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Danoprevir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ѳ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Is an HCV NS3 protease inhibitor [
     <xref rid="B73-medicina-56-00386" ref-type="bibr">73</xref>].
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>↑ Increases; ↓ Decreases; Ѳ Suppresses.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
